您的购物车当前为空
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.

LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 20,500 | 3-6月 | |
| 50 mg | ¥ 27,300 | 3-6月 | |
| 100 mg | ¥ 35,500 | 3-6月 |
LHC-165 相关产品
| 产品描述 | LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors. |
| 分子量 | 603.55 |
| 分子式 | C29H32F2N3O7P |
| CAS No. | 1258595-14-0 |
| 密度 | 1.414 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | 1M NaOH: 50 mg/mL (82.84 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
1M NaOH
| |||||||||||||||||||||||||||||||
评论内容